Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19

Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19

Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of indeterminate potential (CHIP) has emerged as a risk factor for chronic i...

Full description

Bibliographic Details
Main Authors: Nicolas Duployez, Jordane Demonchy, Céline Berthon, Julien Goutay, Morgan Caplan, Anne-Sophie Moreau, Anne Bignon, Alice Marceau-Renaut, Delphine Garrigue, Imelda Raczkiewicz, Sandrine Geffroy, Maxime Bucci, Kazali Alidjinou, Julie Demaret, Myriam Labalette, Thierry Brousseau, Annabelle Dupont, Antoine Rauch, Julien Poissy, Sophie Susen, Claude Preudhomme, Bruno Quesnel
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
SARS-CoV-2
COVID-19
clonal hematopoiesis
CHIP
sequencing
<i>DNMT3A</i>
Online Access:https://www.mdpi.com/2072-6694/12/7/1992

Internet

https://www.mdpi.com/2072-6694/12/7/1992

Similar Items